DexCom (DXCM) Misses Q1 EPS by 20c
Get Alerts DXCM Hot Sheet
Price: $134.00 +1.89%
EPS Growth %: +58.8%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +58.8%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.32, $0.20 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $628.8 million versus the consensus estimate of $624.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.92 billion, versus the consensus of $2.92 billion.
- Non-GAAP Gross Profit Margin of approximately 65%
- Non-GAAP Operating Margin of approximately 16%
- Adjusted EBITDA Margin of approximately 25%
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Intel to report later this week, but analysts flag weakness in chipmaking unit
- Highwoods Properties (HIW) Tops Q1 EPS by 6c, provides guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!